TWI461426B - (二氫)咪唑並異〔5,1-a〕喹啉類 - Google Patents

(二氫)咪唑並異〔5,1-a〕喹啉類 Download PDF

Info

Publication number
TWI461426B
TWI461426B TW099114528A TW99114528A TWI461426B TW I461426 B TWI461426 B TW I461426B TW 099114528 A TW099114528 A TW 099114528A TW 99114528 A TW99114528 A TW 99114528A TW I461426 B TWI461426 B TW I461426B
Authority
TW
Taiwan
Prior art keywords
alkyl
group
vacuo
concentrated
methoxy
Prior art date
Application number
TW099114528A
Other languages
English (en)
Chinese (zh)
Other versions
TW201107322A (en
Inventor
Hubert Jan Jozef Loozen
Cornelis Marius Timmers
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of TW201107322A publication Critical patent/TW201107322A/zh
Application granted granted Critical
Publication of TWI461426B publication Critical patent/TWI461426B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW099114528A 2009-05-27 2010-05-06 (二氫)咪唑並異〔5,1-a〕喹啉類 TWI461426B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09161274 2009-05-27

Publications (2)

Publication Number Publication Date
TW201107322A TW201107322A (en) 2011-03-01
TWI461426B true TWI461426B (zh) 2014-11-21

Family

ID=42315817

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099114528A TWI461426B (zh) 2009-05-27 2010-05-06 (二氫)咪唑並異〔5,1-a〕喹啉類

Country Status (8)

Country Link
EP (1) EP2435433B1 (enExample)
JP (1) JP5647675B2 (enExample)
CN (1) CN102448961B (enExample)
AR (1) AR076703A1 (enExample)
AU (1) AU2010252007B2 (enExample)
CA (1) CA2763118A1 (enExample)
TW (1) TWI461426B (enExample)
WO (1) WO2010136438A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2796774T3 (es) 2011-07-01 2020-11-30 Merck Patent Gmbh Dihidropirazoles, composiciones farmacéuticas de los mismos y su uso para el tratamiento de trastornos de fertilidad
CA2834199C (en) 2011-07-18 2020-01-07 Merck Patent Gmbh Benzamides as allosteric modulators of the fsh receptor
CN104080784B (zh) 2012-01-10 2017-07-18 默克专利有限公司 用作卵泡刺激素调节剂的苯甲酰胺衍生物
BR112014019351A8 (pt) * 2012-02-08 2017-07-11 Merck Patent Gmbh Análogos de tiazolidinona deuterados como agonistas para o receptor do hormônio folículo estimulante
CA2912921C (en) * 2013-06-24 2021-05-18 Merck Patent Gmbh Pyrazole compounds as modulators of fshr and uses thereof
EP3013823B1 (en) 2013-06-24 2017-11-01 Merck Patent GmbH Imidazole compounds as modulators of fshr and uses thereof
ME03654B (me) 2014-02-13 2020-07-20 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
TW201613860A (en) 2014-02-13 2016-04-16 Incyte Corp Cyclopropylamines as LSD1 inhibitors
PT3105226T (pt) 2014-02-13 2019-11-06 Incyte Corp Ciclopropilaminas como inibidores de lsd1
WO2015196335A1 (en) 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
AU2016243939B2 (en) 2015-04-03 2020-09-03 Incyte Holdings Corporation Heterocyclic compounds as LSD1 inhibitors
KR102710120B1 (ko) 2015-08-12 2024-09-27 인사이트 홀딩스 코포레이션 Lsd1 저해제의 염
AR109452A1 (es) 2016-04-22 2018-12-12 Incyte Corp Formulación farmacéutica de un inhibidor de lsd1 y método de tratamiento
CN106866692A (zh) * 2017-03-30 2017-06-20 毛阿龙 具有苯并1,4‑二氧杂环己二烯酮结构的fshr拮抗剂的制备方法
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
EP4598928A1 (en) * 2022-10-05 2025-08-13 Radionetics Oncology, Inc. Follicle-stimulating hormone receptor (fshr) targeted therapeutics and uses thereof
KR20250157379A (ko) 2023-03-08 2025-11-04 훼링 비.브이. 소분자 fsh 수용체 조절제

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008015A2 (en) * 1998-08-07 2000-02-17 Applied Research Systems Ars Holding N.V. Fsh mimetics for the treatment of infertility
WO2003004028A1 (en) * 2001-07-02 2003-01-16 Akzo Nobel N.V. Tetrahydroquinoline derivatives
US20040259792A1 (en) * 2003-04-01 2004-12-23 Palmer Stephen S. Inhibitors of phosphodiesterases in infertility

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO66059A (ro) * 1973-05-25 1981-05-30 Gruppo Lepetit Spa,It Procedeu de obtinere a unor derivati de triazolochinoline
PH15001A (en) * 1977-07-25 1982-03-22 Sandoz Ag Prolactin secretion inhibitors
CA2530316A1 (en) * 2003-06-30 2005-01-13 Altana Pharma Ag Pyrrolodihydroisoquinolines as pde10 inhibitors
TW200944523A (en) * 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008015A2 (en) * 1998-08-07 2000-02-17 Applied Research Systems Ars Holding N.V. Fsh mimetics for the treatment of infertility
WO2003004028A1 (en) * 2001-07-02 2003-01-16 Akzo Nobel N.V. Tetrahydroquinoline derivatives
US20040259792A1 (en) * 2003-04-01 2004-12-23 Palmer Stephen S. Inhibitors of phosphodiesterases in infertility

Also Published As

Publication number Publication date
CN102448961A (zh) 2012-05-09
CA2763118A1 (en) 2010-12-02
WO2010136438A1 (en) 2010-12-02
TW201107322A (en) 2011-03-01
EP2435433A1 (en) 2012-04-04
JP2012528105A (ja) 2012-11-12
AU2010252007A1 (en) 2011-12-22
JP5647675B2 (ja) 2015-01-07
AU2010252007B2 (en) 2014-06-05
EP2435433B1 (en) 2013-08-28
CN102448961B (zh) 2016-01-06
AR076703A1 (es) 2011-06-29

Similar Documents

Publication Publication Date Title
TWI461426B (zh) (二氫)咪唑並異〔5,1-a〕喹啉類
KR102384668B1 (ko) Apj 효능제로서의 6-히드록시-5-(페닐/헤테로아릴술포닐)피리미딘-4(1h)-온
JP5620823B2 (ja) (ジヒドロ)ピロロ[2,1−a]イソキノリン
CN105120862A (zh) Wnt信号途径的3-(苯并咪唑-2-基)-吲唑抑制剂及其治疗应用
CN101490014A (zh) 苯并咪唑和氮杂苯并咪唑的区域选择性钯催化合成
TW201725203A (zh) 作為apj受體促效劑之雜芳基羥基嘧啶酮
CN110072850A (zh) 3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
EP2079738A2 (en) 7-azaindole derivatives as c-met kinase inhibitors
JP2013541592A (ja) ヘキサヒドロインデノピリジン及びオクタヒドロベンゾキノリンのアリール−及びヘテロアリールカルボニル誘導体
CN105189508B (zh) 作为janus激酶抑制剂的环烷基腈吡唑并吡啶酮
KR20200083529A (ko) 파르네소이드 x 수용체 조정제로서의 알켄 스피로시클릭 화합물
IL186831A (en) History 4 - Phenyl - 5 - Oxo - 8,7,6,5,4,1 - Hexahydroquinoline as a drug for the treatment of infertility
KR20090074179A (ko) Ppar 조절제로서 유용한 1h­인돌­2­카르복실산 유도체
US8431564B2 (en) Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
CA2849111C (en) Fsh receptor antagonists
RU2530775C2 (ru) ПРОИЗВОДНЫЕ 1Н-ПИРАЗОЛО[4,3-c]ИЗОХИНОЛИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ В ТЕРАПИИ
EP2459551B1 (en) Dihydrobenzoindazoles
US8071589B2 (en) Dihydrobenzoindazoles
US8071587B2 (en) (Dihydro)imidazoiso[5,1-A]quinolines
TW201116531A (en) Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
TW200524902A (en) 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
CN119176808B (zh) 一种glp-1激动剂及其制备方法和应用
CN119176808A (zh) 一种glp-1激动剂及其制备方法和应用
MXPA05006588A (es) Compuestos de pirazol como derivados antagonistas del receptor de la integrina.
HK1124044A (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees